Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
2.100
-0.990 (-32.04%)
At close: Oct 29, 2025, 4:00 PM EDT
2.090
-0.010 (-0.48%)
After-hours: Oct 29, 2025, 7:59 PM EDT
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $556.8 million as of October 29, 2025. Its market cap has increased by 100.58% in one year.
Market Cap
556.80M
Enterprise Value
615.39M
1-Year Change
100.58%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has increased from $488.10M to $556.80M, an increase of 14.08%. That is a compound annual growth rate of 1.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 819.30M | 97.66% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
| Mar 20, 2014 | 488.10M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.02B |
| Johnson & Johnson | 448.18B |
| AbbVie | 400.13B |
| UnitedHealth Group | 322.66B |
| AstraZeneca | 257.84B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 217.63B |